ReviewThe Lancet. Oncology2020

Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy.

Lisa Bodei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.